In This Story
Prestige Consumer Healthcare Inc (PBH+0.10%). has submitted its 10-Q filing for the quarterly period ended September 30, 2024.
The filing includes financial statements for the quarter, showing a decrease in net sales to $283,548,000 from $286,307,000 in the same quarter the previous year. The decrease is attributed to reduced sales in the North American OTC Healthcare segment.
Cost of sales for the quarter was $126,403,000, compared to $126,296,000 in the same quarter of the previous year. The slight increase is due to higher supply chain costs.
The company reported a gross profit of $157,382,000 for the quarter, compared to $160,020,000 in the previous year, with the decline attributed to decreased sales and increased costs.
Operating income for the quarter was $84,339,000, down from $88,250,000 in the previous year. The decline is due to lower gross profit and increased operating expenses.
Net income for the quarter was $54,377,000, compared to $53,559,000 in the previous year. Earnings per share were $1.10, compared to $1.08 in the previous year.
Cash provided by operating activities was $124,576,000, while cash used in investing and financing activities was $4,157,000 and $116,722,000, respectively.
Prestige had a working capital of $380,708,000 as of September 30, 2024. The company maintains its focus on managing its financial resources effectively to meet future obligations.
The filing also details various financial agreements, including long-term debt arrangements and the company's stock repurchase program.
Prestige does not anticipate cash dividend payments to common stockholders in the near future.
The company continues to focus on its core OTC healthcare products and highlights its efforts to manage supply chain challenges and cost pressures.
This content was summarized by generative artificial intelligence using public filings retrieved from SEC.gov. The original data was derived from the Prestige Consumer Healthcare Inc. quarterly 10-Q report dated November 7, 2024. To report an error, please email earnings@qz.com.